PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jathtrainLink to Publisher's site
 
J Athl Train. 1999 Oct-Dec; 34(4): 338–341.
PMCID: PMC1323341

Serum Dexamethasone Levels After Decadron Phonophoresis

Heather Darrow, MS, ATC,* Shane Schulthies, PhD, PT, ATC,* David Draper, EdD, ATC,* Mark Ricard, PhD,* and Gary J. Measom, RN, PhD

Abstract

Objective:

To determine serum levels of dexamethasone at several intervals after administration of Decadron (dexamethasone sodium phosphate) phonophoresis.

Design and Setting:

This study was designed as a 2-factor analysis of variance with repeated measures on 1 factor (blood draws). Independent variables were group (gel/sham, gel/ ultrasound, dexamethasone/sham, dexamethasone/ultrasound) and blood draws (pretreatment, posttreatment, 15 minutes, and 30 minutes). The dependent variable was the serum level of dexamethasone.

Subjects:

Forty healthy college students (21 males, 19 females; mean age = 22 ± 1.3 years) with no known drug allergies or current medication use were randomly assigned to 1 of 4 treatment groups. The treatment site was the left forearm.

Measurements:

After the pretreatment blood draw, a 10- minute ultrasound treatment was administered, followed by a posttreatment blood draw. Two additional blood draws followed at 15-minute intervals. A total of 4 serum samples (5 cc each) from each subject were centrifuged, and the pipetted serum was frozen for later analysis by double antibody radioimmunoassay.

Results:

No significant amounts of serum dexamethasone were detected in 12 consecutive samples. Testing of additional samples was, therefore, discontinued.

Conclusions:

Decadron phonophoresis as used in this experiment did not result in detectable serum levels of dexamethasone. More study is needed to validate the efficacy of Decadron phonophoresis on serum dexamethasone levels.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (796K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • GRIFFIN JE, TOUCHSTONE JC. Ultrasonic movement of cortisol into pig tissues. I. Movement into skeletal muscle. Am J Phys Med. 1963 Apr;42:77–85. [PubMed]
  • GRIFFIN JE, TOUCHSTONE JC, LIU AC. ULTRASONIC MOVEMENT OF CORTISOL INTO PIG TISSUE. II. MOVEMENT INTO PARAVERTEBRAL NERVE. Am J Phys Med. 1965 Feb;44:20–25. [PubMed]
  • Davick JP, Martin RK, Albright JP. Distribution and deposition of tritiated cortisol using phonophoresis. Phys Ther. 1988 Nov;68(11):1672–1675. [PubMed]
  • Cameron MH, Monroe LG. Relative transmission of ultrasound by media customarily used for phonophoresis. Phys Ther. 1992 Feb;72(2):142–148. [PubMed]
  • Bare AC, McAnaw MB, Pritchard AE, Struebing JG, Smutok MA, Christie DS, Domenech MA, Bare MA, Bloodworth ML, Seal LA. Phonophoretic delivery of 10% hydrocortisone through the epidermis of humans as determined by serum cortisol concentrations. Phys Ther. 1996 Jul;76(7):738–749. [PubMed]
  • Griffin JE, Echternach JL, Price RE, Touchstone JC. Patients treated with ultrasonic driven hydrocortisone and with ultrasound alone. Phys Ther. 1967 Jul;47(7):594–601. [PubMed]
  • Griffin JE, Touchstone JC. Low-intensity phonophoresis of cortisol in swine. Phys Ther. 1968 Dec;48(12):1336–1344. [PubMed]
  • Griffin JE, Touchstone JC. Effects of ultrasonic frequency on phonophoresis of cortisol into swine tissues. Am J Phys Med. 1972 Apr;51(2):62–78. [PubMed]
  • Kleinkort JA, Wood F. Phonophoresis with 1 percent versus 10 percent hydrocortisone. Phys Ther. 1975 Dec;55(12):1320–1324. [PubMed]
  • Wing M. Phonophoresis with hydrocortisone in the treatment of temporomandibular joint dysfunction. Phys Ther. 1982 Jan;62(1):32–33. [PubMed]
  • Saunders NJ. American folk medicine. Med Hist. 1983 Jan;27(1):b100–101. [PMC free article]
  • Byl NN, McKenzie A, Halliday B, Wong T, O'Connell J. The effects of phonophoresis with corticosteroids: a controlled pilot study. J Orthop Sports Phys Ther. 1993 Nov;18(5):590–600. [PubMed]
  • Benson HA, McElnay JC, Harland R. Use of ultrasound to enhance percutaneous absorption of benzydamine. Phys Ther. 1989 Feb;69(2):113–118. [PubMed]
  • Oziomek RS, Perrin DH, Herold DA, Denegar CR. Effect of phonophoresis on serum salicylate levels. Med Sci Sports Exerc. 1991 Apr;23(4):397–401. [PubMed]
  • Mitragotri S, Blankschtein D, Langer R. Ultrasound-mediated transdermal protein delivery. Science. 1995 Aug 11;269(5225):850–853. [PubMed]
  • Mitragotri S, Edwards DA, Blankschtein D, Langer R. A mechanistic study of ultrasonically-enhanced transdermal drug delivery. J Pharm Sci. 1995 Jun;84(6):697–706. [PubMed]
  • Bommannan D, Okuyama H, Stauffer P, Guy RH. Sonophoresis. I. The use of high-frequency ultrasound to enhance transdermal drug delivery. Pharm Res. 1992 Apr;9(4):559–564. [PubMed]
  • Bommannan D, Menon GK, Okuyama H, Elias PM, Guy RH. Sonophoresis. II. Examination of the mechanism(s) of ultrasound-enhanced transdermal drug delivery. Pharm Res. 1992 Aug;9(8):1043–1047. [PubMed]
  • Meikle AW, Lagerquist LG, Tyler FH. A plasma dexamethasone radioimmunoassay. Steroids. 1973 Aug;22(2):193–202. [PubMed]

Articles from Journal of Athletic Training are provided here courtesy of National Athletic Trainers Association